IL151943A0 - HUMAN AMINOACYL-tRNA SYNTHETASE POLYPETIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS - Google Patents

HUMAN AMINOACYL-tRNA SYNTHETASE POLYPETIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS

Info

Publication number
IL151943A0
IL151943A0 IL15194301A IL15194301A IL151943A0 IL 151943 A0 IL151943 A0 IL 151943A0 IL 15194301 A IL15194301 A IL 15194301A IL 15194301 A IL15194301 A IL 15194301A IL 151943 A0 IL151943 A0 IL 151943A0
Authority
IL
Israel
Prior art keywords
trna synthetase
useful
angiogenesis
regulation
human aminoacyl
Prior art date
Application number
IL15194301A
Other languages
English (en)
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Publication of IL151943A0 publication Critical patent/IL151943A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/515—Angiogenesic factors; Angiogenin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
IL15194301A 2000-03-31 2001-03-21 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPETIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS IL151943A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19347100P 2000-03-31 2000-03-31
PCT/US2001/008966 WO2001074841A1 (en) 2000-03-31 2001-03-21 Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis

Publications (1)

Publication Number Publication Date
IL151943A0 true IL151943A0 (en) 2003-04-10

Family

ID=22713774

Family Applications (5)

Application Number Title Priority Date Filing Date
IL15194001A IL151940A0 (en) 2000-03-31 2001-03-21 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPETIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS
IL15194301A IL151943A0 (en) 2000-03-31 2001-03-21 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPETIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS
IL151943A IL151943A (en) 2000-03-31 2002-09-26 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPETIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS
IL195677A IL195677A (en) 2000-03-31 2008-12-02 Nucleic acid encoding truncated tryptophanyl trna synthetase
IL195854A IL195854A (en) 2000-03-31 2008-12-10 Aminoacyl polypeptides - trna human synthesis used to regulate angiogenesis

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL15194001A IL151940A0 (en) 2000-03-31 2001-03-21 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPETIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS

Family Applications After (3)

Application Number Title Priority Date Filing Date
IL151943A IL151943A (en) 2000-03-31 2002-09-26 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPETIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS
IL195677A IL195677A (en) 2000-03-31 2008-12-02 Nucleic acid encoding truncated tryptophanyl trna synthetase
IL195854A IL195854A (en) 2000-03-31 2008-12-10 Aminoacyl polypeptides - trna human synthesis used to regulate angiogenesis

Country Status (10)

Country Link
US (5) US7067126B2 (de)
EP (3) EP1274834B1 (de)
JP (2) JP5036115B2 (de)
AT (1) ATE473275T1 (de)
AU (6) AU5090401A (de)
CA (2) CA2404488C (de)
DE (1) DE60142508D1 (de)
IL (5) IL151940A0 (de)
NZ (2) NZ522182A (de)
WO (2) WO2001074841A1 (de)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7273844B2 (en) 2000-03-31 2007-09-25 The Scripps Research Institute Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis
WO2001074841A1 (en) * 2000-03-31 2001-10-11 The Scripps Research Institute Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis
US7144984B2 (en) * 2000-03-31 2006-12-05 The Scripps Research Institute Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
JP4361734B2 (ja) * 2001-02-23 2009-11-11 ザ・スクリプス・リサーチ・インステイチユート 血管形成の調節に有用なトリプトファニル−ｔＲＮＡシンテターゼ由来ポリペプチド
US6903189B2 (en) * 2001-03-21 2005-06-07 The Scripps Research Institute Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
JPWO2004022082A1 (ja) * 2002-09-04 2005-12-22 株式会社プロテイン・エクスプレス 胚着床制御剤
EP1765362B1 (de) * 2004-06-04 2012-03-28 The Scripps Research Institute Zusammensetzungen und verfahren zur behandlung von neovaskulären erkrankungen
US20060079673A1 (en) * 2004-08-02 2006-04-13 Paul Glidden Polynucleotides encoding tRNA synthetase fragments and uses thereof
US8282921B2 (en) 2004-08-02 2012-10-09 Paul Glidden tRNA synthetase fragments
CA2478458A1 (en) * 2004-08-20 2006-02-20 Michael Panzara Treatment of pediatric multiple sclerosis
CN101102792A (zh) * 2004-11-19 2008-01-09 比奥根艾迪克Ma公司 治疗多发性硬化
CN101179935A (zh) * 2005-02-24 2008-05-14 斯克里普斯研究学院 缺血性视网膜组织的血管再生和为此目的的筛选方法
WO2007064941A2 (en) * 2005-12-02 2007-06-07 The Scripps Research Institute Angiogenic tyrosyl trna synthetase compositions and methods
MX2010010068A (es) * 2008-03-11 2010-10-04 Univ North Carolina Composiciones angiostaticas que comprenden polipeptidos de tirosil-acido ribonucleico de transferencia sintetasa truncado y metodos de uso de las mismas.
CA2727622A1 (en) 2008-06-11 2009-12-17 Atyr Pharma, Inc. Thrombopoietic activity of tyrosyl-trna synthetase polypeptides
JP5756751B2 (ja) 2008-06-26 2015-07-29 エータイアー ファーマ， インコーポレイテッド 非正準的な生物学的活性を有するグリシル−ｔＲＮＡ合成酵素を含む組成物および方法
ES2552773T3 (es) 2009-02-27 2015-12-02 Atyr Pharma, Inc. Motivos estructurales de polipéptidos asociados con la actividad de señalización celular
US8510665B2 (en) * 2009-03-16 2013-08-13 Apple Inc. Methods and graphical user interfaces for editing on a multifunction device with a touch screen display
JP5730280B2 (ja) 2009-03-16 2015-06-03 パング バイオファーマ リミテッド 非カノニカル生物学的活性を有するヒスチジル−ｔＲＮＡシンテターゼスプライスバリアントを含む組成物および方法
JP5848236B2 (ja) 2009-03-31 2016-01-27 エータイアー ファーマ， インコーポレイテッド 非標準的な生物活性を有するアスパルチルｔＲＮＡ合成酵素を含む組成物および方法
CA2758548A1 (en) * 2009-04-17 2010-10-21 Biogen Idec Ma Inc. Compositions and methods to treat acute myelogenous leukemia
EP2509625B1 (de) 2009-12-11 2015-01-28 Atyr Pharma, Inc. Histidyl trna-synthetasen zur entzündungshemmung
US8828395B2 (en) 2009-12-11 2014-09-09 Atyr Pharma, Inc. Antibodies that bind tyrosyl-tRNA synthetases
US20110150885A1 (en) * 2009-12-11 2011-06-23 Atyr Pharma, Inc. Aminoacyl trna synthetases for modulating hematopoiesis
WO2011097031A2 (en) * 2010-02-04 2011-08-11 The Scripps Research Institute Monomeric forms of human aminoacyl-trna synthetases having non-canonical biological activities
PL2558499T3 (pl) 2010-04-16 2017-10-31 Biogen Ma Inc Przeciwciała anty-VLA-4
CA2797093C (en) 2010-04-26 2019-10-29 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase
CN103096910A (zh) 2010-04-27 2013-05-08 Atyr医药公司 与苏氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
CN103096911B (zh) 2010-04-27 2018-05-29 Atyr 医药公司 与异亮氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
JP6008837B2 (ja) * 2010-04-28 2016-10-19 エータイアー ファーマ， インコーポレイテッド アラニルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
AU2011248490B2 (en) 2010-04-29 2016-11-10 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Asparaginyl tRNA synthetases
US9068177B2 (en) 2010-04-29 2015-06-30 Atyr Pharma, Inc Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-tRNA synthetases
CA2797393C (en) 2010-04-29 2020-03-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases
CN103096912A (zh) 2010-05-03 2013-05-08 Atyr医药公司 与苯丙氨酰-α-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
CA2797799C (en) 2010-05-03 2020-12-08 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of seryl-trna synthetases
CA2797978C (en) 2010-05-03 2019-12-03 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases
CA2797277C (en) 2010-05-03 2021-02-23 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases
AU2011248101B2 (en) 2010-05-04 2016-10-20 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-tRNA synthetase complex
AU2011248100B2 (en) 2010-05-04 2017-01-19 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutamyl-prolyl-tRNA synthetases
CN103200953B (zh) 2010-05-14 2017-02-15 Atyr 医药公司 与苯丙氨酰‑β‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
US9034598B2 (en) 2010-05-17 2015-05-19 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases
WO2011153277A2 (en) 2010-06-01 2011-12-08 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases
EA030461B1 (ru) 2010-07-12 2018-08-31 ЭйТИР ФАРМА, ИНК. ТЕРАПЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И СПОСОБ ДЛЯ ЛЕЧЕНИЯ ВОСПАЛИТЕЛЬНОГО НАРУШЕНИЯ, ГИПЕРХОЛЕСТЕРИНЕМИИ, ГИПЕРЛИПИДЕМИИ, ДИАБЕТА 1 И 2 ТИПА, ПОЛИПЕПТИД АМИНОАЦИЛ-тРНК-СИНТЕТАЗЫ (AARS)
US8999321B2 (en) 2010-07-12 2015-04-07 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
AU2011289833C1 (en) 2010-07-12 2017-06-15 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Histidyl-tRNA synthetases
EP2593125B1 (de) 2010-07-12 2017-11-01 aTyr Pharma, Inc. Innovative erkennung therapeutischer, diagnostischer und antikörperhaltiger zusammensetzungen in zusammenhang mit proteinfragmenten von glycyl-trna-synthetasen
EP2608801B1 (de) 2010-08-25 2019-08-21 aTyr Pharma, Inc. Innovative erkennung therapeutischer, diagnostischer und antikörperhaltiger zusammensetzungen in zusammenhang mit proteinfragmenten von tyrosyl-trna-synthetasen
WO2012048125A2 (en) 2010-10-06 2012-04-12 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of tryptophanyl trna synthetases
RU2613330C2 (ru) * 2011-05-04 2017-03-16 Бореалис Аг Полимерная композиция для электротехнических устройств
RU2457837C1 (ru) * 2011-07-15 2012-08-10 Федеральное государственное бюджетное учреждение науки Иркутский институт химии им. А.Е. Фаворского Сибирского отделения Российской академии наук КОМПЛЕКС ТРИС-(2-ГИДРОКСИЭТИЛ)АМИНА С БИС-(2-МЕТИЛФЕНОКСИАЦЕТАТОМ) ЦИНКА, ПОВЫШАЮЩИЙ ЦИТОКИННУЮ АКТИВНОСТЬ СУММАРНОЙ ТРИПТОФАНИЛ-тРНК-СИНТЕТАЗЫ
WO2013022982A2 (en) 2011-08-09 2013-02-14 Atyr Pharma, Inc. Pegylated tyrosyl-trna synthetase polypeptides
US9816084B2 (en) 2011-12-06 2017-11-14 Atyr Pharma, Inc. Aspartyl-tRNA synthetases
WO2013086228A1 (en) 2011-12-06 2013-06-13 Atyr Pharma, Inc. Pegylated aspartyl-trna synthetase polypeptides
CN104220461A (zh) 2011-12-29 2014-12-17 Atyr医药公司 天冬氨酰-tRNA合成酶-FC缀合物
MX356107B (es) 2012-02-16 2018-05-15 Atyr Pharma Inc Histidil-arnt sintetasas para tratar enfermedades autoinmunes e inflamatorias.
US9587235B2 (en) 2013-03-15 2017-03-07 Atyr Pharma, Inc. Histidyl-tRNA synthetase-Fc conjugates
CN106456721A (zh) * 2014-03-13 2017-02-22 新加坡国立大学 调节wars2的方法
DE102015110437B4 (de) * 2015-06-29 2020-10-08 Infineon Technologies Ag Halbleitervorrichtung mit einer Metallstruktur, die mit einer leitfähigen Struktur elektrisch verbunden ist und Verfahren zur Herstellung
KR101771068B1 (ko) 2015-07-14 2017-08-24 재단법인 의약바이오컨버젼스연구단 케모카인 활성을 가지는 신규한 폴리펩타이드
AU2018256435A1 (en) 2017-04-20 2019-11-07 Atyr Pharma, Inc. Compositions and methods for treating lung inflammation
EP3800999A4 (de) 2018-06-04 2022-06-01 Biogen MA Inc. Anti-vla-4-antikörper mit reduzierter effektorfunktion
US20220268787A1 (en) * 2019-07-18 2022-08-25 Jw Bioscience Antibody specifically binding to wrs protein, and use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3654090A (en) 1968-09-24 1972-04-04 Organon Method for the determination of antigens and antibodies
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US4016043A (en) 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
US4493795A (en) 1983-10-17 1985-01-15 Syntex (U.S.A.) Inc. Synthetic peptide sequences useful in biological and pharmaceutical applications and methods of manufacture
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5885798A (en) * 1996-08-28 1999-03-23 Incyte Pharmaceuticals, Inc. DNA encoding a monocyte activating cytokine
WO2001074841A1 (en) * 2000-03-31 2001-10-11 The Scripps Research Institute Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis
US7273844B2 (en) 2000-03-31 2007-09-25 The Scripps Research Institute Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis
US7144984B2 (en) * 2000-03-31 2006-12-05 The Scripps Research Institute Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
US6903189B2 (en) * 2001-03-21 2005-06-07 The Scripps Research Institute Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis

Also Published As

Publication number Publication date
CA2404484A1 (en) 2001-10-11
EP2258834A1 (de) 2010-12-08
US20120263702A1 (en) 2012-10-18
AU5090401A (en) 2001-10-15
EP1274834A1 (de) 2003-01-15
IL151943A (en) 2009-08-03
US20040009163A1 (en) 2004-01-15
JP2003529354A (ja) 2003-10-07
US20110110917A1 (en) 2011-05-12
EP1274834B1 (de) 2010-07-07
US8562977B2 (en) 2013-10-22
AU2006220352B2 (en) 2009-11-12
JP2004500121A (ja) 2004-01-08
EP1272506A4 (de) 2004-06-02
CA2404488C (en) 2012-01-10
AU2010200514A1 (en) 2010-03-04
IL195677A (en) 2011-05-31
JP4868681B2 (ja) 2012-02-01
DE60142508D1 (de) 2010-08-19
AU2001245899B2 (en) 2006-06-15
AU2010200514B2 (en) 2012-03-15
IL195854A (en) 2015-01-29
CA2404488A1 (en) 2001-10-11
US7521215B2 (en) 2009-04-21
WO2001074841A1 (en) 2001-10-11
US8148125B2 (en) 2012-04-03
WO2001075078A1 (en) 2001-10-11
US20090227662A1 (en) 2009-09-10
EP1272506B1 (de) 2015-07-29
NZ522182A (en) 2005-07-29
NZ522183A (en) 2006-02-24
ATE473275T1 (de) 2010-07-15
AU2001250904B2 (en) 2006-04-13
US20060216745A1 (en) 2006-09-28
US7901917B2 (en) 2011-03-08
AU2006220352A1 (en) 2006-10-12
EP1274834A4 (de) 2004-06-09
JP5036115B2 (ja) 2012-09-26
EP1272506A1 (de) 2003-01-08
AU4589901A (en) 2001-10-15
IL151940A0 (en) 2003-04-10
US7067126B2 (en) 2006-06-27
EP2258834B1 (de) 2015-09-23
CA2404484C (en) 2017-04-18

Similar Documents

Publication Publication Date Title
IL151943A0 (en) HUMAN AMINOACYL-tRNA SYNTHETASE POLYPETIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS
IL149459A0 (en) Recombinant gelatins
EP2267010A3 (de) Aktivierbare rekombinante Neurotoxine
MY133377A (en) Anti-il-12 antibodies, compositions, methods and uses
NL300605I2 (de)
EP1454138A4 (de) Immunocytokine mit modulierter selektivität
YU19903A (sh) Novi receptor nukleinskih kiselina i polipeptida
CA2395266A1 (en) Use of acid-stable subtilisin proteases in animal feed
HK1083351A1 (en) Site specific incorporation of keto amino acids into proteins
IL143670A0 (en) Methods for the expression of active protein-immunoglobulin fusions, active protein-immunoglobulin fusions obtained thereby and pharmaceutical compositions containing the same
IL196900A (en) Autologous T cell vaccine compositions
WO2004046365A3 (en) Interferon-alpha polypeptides and conjugates
IL165080A0 (en) Method and reagents for n-alkylating ureides
ZA200509838B (en) Biologically active peptides
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
AU703179B2 (en) Recombinant canine gastric lipase and pharmaceutical compositions
WO2003057835A3 (en) Pak5-related compositions and methods
WO2003040342A3 (en) Method for generation of modular polynucleotides using solid supports
WO2003027139A3 (en) Novel purified polypeptides involved in membrane biosynthesis
MXPA04004262A (es) Delta-1-pirrolinas.
WO2005001060A3 (en) Novel calcium channel
WO1999005264A3 (de) Herstellung humaner mutierter proteine in humanen zellen mittels homologer rekombination
TW200519206A (en) Methods for producing novel medaka and novel medaka
ITMI931034A1 (it) Processo per la preparazione di proteine inibenti i ribosomi